Skip to content

Clinical trials

Phase 1 Prostatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20162
20172
20182
20192
20203
20213
20222
20238
202414
202510
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting25
Unknown status16
Completed8
Active, not recruiting7
Not yet recruiting3
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital6
Anhui Provincial Hospital4
Eli Lilly and Company3
First Affiliated Hospital of Fujian Medical University3
Janssen Research & Development, LLC3
Jiangsu HengRui Medicine Co., Ltd.3
Affiliated Hospital of Jiangnan University2
FindCure Biosciences (ZhongShan) Co., Ltd.2
Hangzhou DAC Biotechnology Co., Ltd.2
Impact Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms62
Breast Neoplasms11
Ovarian Neoplasms10
Esophageal Neoplasms5
Neoplasm Metastasis5
Pancreatic Neoplasms5
Stomach Neoplasms5
Endometrial Neoplasms4
Urinary Bladder Neoplasms4
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.